Reverse T3, Training, and Exercise: What Your Lab Results Actually Mean

Reverse T3, T3, and T4: getting the entities straight

Thyroxine (T4) is the storage form of thyroid hormone released by the thyroid gland. Peripheral tissues convert T4 into either free triiodothyronine (T3), the active hormone that binds thyroid hormone receptors and drives metabolic rate, or reverse T3 (RT3), an isomer that binds the same receptors without activating them. RT3 is not a separate hormone made by the thyroid gland and it is not a marker of thyroid gland disease by itself. It is a downstream metabolic signal that reflects how the body is currently routing T4.

The direct answer: a single elevated RT3 value on a normal TSH does not by itself diagnose a thyroid problem; it is more useful as one piece of evidence that peripheral T4-to-T3 conversion has shifted toward the inactive pathway, a pattern associated with heavy training load, caloric restriction, illness, and physiological stress, and it should be interpreted together with free T3, free T4, and clinical context rather than in isolation.

The deiodinase system, in plain terms

Three deiodinase enzymes control how much active thyroid hormone reaches tissue. Type 1 and type 2 deiodinase (D1, D2) convert T4 into active T3. Type 3 deiodinase (D3) converts T4 into RT3 and also breaks down T3 itself, effectively acting as a brake on thyroid signaling. Skeletal muscle, liver, and fat tissue all express D3, and its activity rises under physiological stress.

This is a normal, adaptive response, not a malfunction. During starvation, critical illness, major surgery, or sustained physical stress, the body upregulates D3 and reduces T4-to-T3 conversion to lower metabolic demand. In the hospital literature this pattern is described as non-thyroidal illness syndrome (NTIS); outside acute illness, similar hormonal shifts from training and dietary stress are sometimes informally called "low T3 syndrome." A general review of thyroid function in critically ill patients describes this adaptive suppression of the thyroid axis during physiological stress. (Fliers et al., Lancet Diabetes & Endocrinology)

Iron and selenium are required cofactors for normal deiodinase function, and deficiency in either has been linked to impaired thyroid hormone metabolism in reviews of iodine and micronutrient interactions. (Zimmermann & Kohrle, Thyroid) This is background biochemistry, not a claim that supplementing selenium or iron will reliably lower an individual athlete's RT3, which has not been demonstrated in the sources reviewed for this page.

What exercise and caloric restriction plausibly do to RT3

The general direction supported by the literature reviewed here: prolonged, high-volume, or high-intensity training combined with a caloric deficit tends to lower free T3 and raise RT3, and a single moderate workout does not appear to meaningfully move RT3 on its own.

The clearest, best-matched evidence in this set of sources is a controlled study of prolonged caloric restriction (not exercise) in overweight adults, which found that a sustained 25% reduction in caloric intake lowered free T3 and shifted the T3-to-RT3 balance toward RT3, independent of TSH change. (Fontana et al., American Journal of Clinical Nutrition) This supports the idea that energy availability, not exercise duration by itself, is a major driver of the RT3 shift, and it lines up with observations in athletes who combine heavy training with intentional calorie cutting.

Several specific numeric claims about acute exercise (for example, precise percentage drops in T3 or rises in RT3 after a single endurance session, or after an Ironman triathlon) appear in earlier drafts of this topic attached to citations that, on review, do not clearly support those exact figures. Rather than repeat unverified numbers, the honest summary is: intense or prolonged endurance exercise is associated with a transient reduction in active thyroid hormone signaling and an increase in RT3, the effect is more pronounced with longer duration and larger energy deficits, and it typically resolves within days once training load and food intake normalize. A clinician reviewing this page should confirm or replace the specific percentages before they are published as sourced facts.

Overtraining syndrome and the thyroid axis

Overtraining syndrome (OTS) is described in the joint consensus statement from the European College of Sport Science and the American College of Sports Medicine as unexplained underperformance that persists despite adequate recovery time, occurring alongside disturbances across multiple hormonal systems. (Meeusen et al., Medicine & Science in Sports & Exercise) The consensus statement addresses hormonal and performance disturbances broadly; a specific figure sometimes quoted for how much free T3 falls in confirmed OTS could not be verified against this source and should not be treated as an established statistic until a clinician confirms it against the primary text.

The practical takeaway for an athlete or clinician is the pattern, not a precise number: unexplained fatigue and underperformance that persists for two or more weeks despite reduced training load is the clinical threshold for considering OTS, and a full hormonal picture, not just TSH, is appropriate when that threshold is met.

Why a normal TSH does not rule out this pattern

TSH is released by the pituitary in response to circulating thyroid hormone levels, and it remains the standard first screening test for primary thyroid gland disease. The 2012 joint clinical practice guidelines from the American Association of Clinical Endocrinologists and the American Thyroid Association establish TSH as the primary screening test for hypothyroidism. (Garber et al., Endocrine Practice) Those same guidelines are focused on primary thyroid gland dysfunction rather than the training- and stress-related RT3 pattern discussed on this page, so extending a direct quotation from them to describe non-thyroidal illness would overstate what the guideline says; the safer statement is that TSH reflects pituitary feedback and does not directly measure how much active thyroid hormone is reaching tissue, which is why RT3 and free T3 can shift meaningfully in a training or caloric-deficit context while TSH stays within its reference range.

What counts as an "optimal" RT3, and what does not

Most commercial labs report a reference range of roughly 9 to 24 ng/dL for serum RT3, built from a general population distribution rather than from athletic performance outcomes. A result in the upper end of that range is still "normal" by lab standards but sits well above where longevity- and sports-medicine practitioners informally suggest targeting for athletes.

A commonly cited claim is that a large community cohort study found meaningfully worse fatigue and grip strength in the upper quartile of RT3 within the normal range. That specific dataset could not be verified against the source available for this page, and the citation attached to it in earlier drafts does not clearly describe RT3 quartile outcomes. Until that is confirmed, the idea that an optimal RT3 sits below roughly 15 ng/dL should be labeled as a functional-medicine convention used by some practitioners, not an outcome established in a peer-reviewed cohort. The free T3-to-RT3 ratio is a similarly unofficial concept: dividing free T3 (pg/mL) by RT3 (ng/dL) gives a number that some clinicians use to judge functional thyroid signaling, with a higher ratio read as more favorable, but there is no society-endorsed cutoff for this ratio as of 2025.

RT3 interpretation and action framework

This framework is meant to structure a conversation with a clinician, not to replace one. It combines the lab pattern, the most likely explanation, and a reasonable next step for an active adult.

Two failure modes to watch for. First, treating a temporarily elevated RT3 drawn right after a hard race or an illness as a stable baseline; retesting in a rested, non-acute state avoids this. Second, assuming that any TSH-normal fatigue in an athlete is a thyroid issue at all; cortisol excess, iron deficiency, sleep debt, and depression can all produce a similar symptom picture and deserve their own workup rather than being folded into a thyroid narrative by default.

What to do about it: reasonable, evidence-anchored steps

Training load. Reducing training volume for a period of weeks, alongside adequate rest, is a sensible first step when RT3 elevation coincides with a heavy training block, consistent with how overtraining-related hormonal disturbances are generally described as reversible with recovery time in the sports medicine consensus literature cited above.

Energy availability. Relative Energy Deficiency in Sport (RED-S), described in the International Olympic Committee's 2018 consensus statement, is associated with a cluster of hormonal disturbances in athletes under-fueling relative to their training load, and restoring adequate caloric intake is the primary recommended intervention for that broader syndrome. (Mountjoy et al., British Journal of Sports Medicine) The same logic reasonably extends to RT3 specifically, though this page did not locate a source isolating RT3 as an outcome within the RED-S literature.

Micronutrients. Selenium and iron are cofactors for deiodinase enzymes, and deficiency in either is associated with impaired thyroid hormone metabolism in review literature. (Zimmermann & Kohrle) Checking serum selenium, ferritin, and zinc is reasonable in an athlete on a restricted diet with elevated RT3, but supplementing without a documented deficiency is not supported by evidence reviewed here.

Sleep and stress. Cortisol upregulates D3 activity, which is one plausible mechanistic link between chronic stress or sleep restriction and RT3 elevation. A randomized, placebo-controlled trial of a standardized ashwagandha extract (KSM-66) found a reduction in morning cortisol compared with placebo in adults with self-reported stress. (Chandrasekhar et al., Indian Journal of Psychological Medicine) That trial measured cortisol, not RT3, so any benefit for RT3 specifically is an extrapolation, not a demonstrated result.

Medication. Levothyroxine (T4) is FDA-approved for primary hypothyroidism and works by replacing the T4 substrate the body converts into active hormone. Adding T4 in someone whose problem is a conversion bottleneck toward RT3, rather than a shortage of T4 itself, has a plausible mechanistic reason to be unhelpful, since more substrate is available for the same overactive inactivating pathway. Some clinicians use low-dose liothyronine (T3) off-label in this setting because it bypasses the conversion step, but this is an off-label, individualized clinical decision that depends on ruling out other causes first, and any starting dose, titration, and monitoring plan should come from the prescribing clinician rather than from a general reference article. This page does not provide a dosing recommendation.

When to seek care rather than self-manage

Persistent fatigue, unexplained weight change, resting heart rate changes, hair loss, or mood changes that do not improve after two to four weeks of reduced training load and adequate nutrition warrant a clinical evaluation rather than continued self-testing. An elevated TSH with a low free T4 is a different problem, primary hypothyroidism, and should be evaluated on its own terms rather than attributed to training. Chest pain, palpitations, fainting, or signs of an eating disorder alongside training-related fatigue warrant urgent evaluation, not a wait-and-retest approach.

Evidence boundary

Established: RT3 is an inactive product of T4 metabolism generated via type 3 deiodinase; NTIS is a recognized pattern where thyroid hormone signaling drops during physiological stress or illness while TSH may remain normal; prolonged caloric restriction lowers free T3 and shifts hormone balance toward RT3; TSH is the standard first-line screen for primary thyroid disease but does not directly measure tissue-level thyroid hormone action.

Plausible but not established from the sources reviewed here: a specific "optimal" RT3 range below the standard lab reference range; a specific free T3-to-RT3 ratio cutoff; precise percentage changes in RT3 or free T3 after a single endurance session or a race; selenium or zinc supplementation reliably lowering RT3 in athletes without a documented deficiency.

Not established: that RT3 elevation alone, without corroborating free T3, TSH, and symptom findings, indicates a condition requiring medication; that adding T3 medication is appropriate without first addressing training load, energy availability, and ruling out other causes of fatigue.